Patient characteristics and overall survival in patients with post-docetaxel metastatic castration-resistant prostate cancer in the community setting
Crossref DOI link: https://doi.org/10.1007/s12032-017-1014-2
Published Online: 2017-08-10
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Oh, William K.
Miao, Raymond
Vekeman, Francis
Sung, Jennifer
Cheng, Wendy Y.
Gauthier-Loiselle, Marjolaine
Dhawan, Ravinder
Duh, Mei Sheng
Funding for this research was provided by:
Sanofi
License valid from 2017-08-10